Stablepharma has initiated its first human trial of SPVX02, a thermostable fridge-free vaccine for tetanus-diphtheria designed to remain potent without…
Read More »
Stablepharma has initiated its first human trial of SPVX02, a thermostable fridge-free vaccine for tetanus-diphtheria designed to remain potent without…
Read More »